305 related articles for article (PubMed ID: 6983379)
21. Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance.
Graves KJ; Ghosh AP; Schmidt N; Augostini P; Secor WE; Schwebke JR; Martin DH; Kissinger PJ; Muzny CA
Clin Infect Dis; 2019 Nov; 69(12):2170-2176. PubMed ID: 30768180
[TBL] [Abstract][Full Text] [Related]
22. Intravenous therapy of metronidazole-resistant Trichomonas vaginalis.
Dombrowski MP; Sokol RJ; Brown WJ; Bronsteen RA
Obstet Gynecol; 1987 Mar; 69(3 Pt 2):524-5. PubMed ID: 3492696
[TBL] [Abstract][Full Text] [Related]
23. Povidone-iodine in the treatment of metronidazole-resistant trichomonas vaginalis.
Wong CA; Wilson PD; Chew TA
Aust N Z J Obstet Gynaecol; 1990 May; 30(2):169-71. PubMed ID: 2400364
[No Abstract] [Full Text] [Related]
24. Treatment of metronidazole-resistant Trichomonas vaginalis.
Goldman LM; Upcroft JA; Workowski K; Rapkin A
Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
[TBL] [Abstract][Full Text] [Related]
25. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
[TBL] [Abstract][Full Text] [Related]
26. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
[TBL] [Abstract][Full Text] [Related]
27. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.
Korosh T; Bujans E; Morada M; Karaalioglu C; Vanden Eynde JJ; Mayence A; Huang TL; Yarlett N
Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056
[TBL] [Abstract][Full Text] [Related]
28. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of amixicile against T. vaginalis from clinical isolates.
Jain E; Zaenker EI; Hoffman PS; Warren CA
Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
[TBL] [Abstract][Full Text] [Related]
30. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.
Rasoloson D; Tomková E; Cammack R; Kulda J; Tachezy J
Parasitology; 2001 Jul; 123(Pt 1):45-56. PubMed ID: 11467782
[TBL] [Abstract][Full Text] [Related]
31. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
32. Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis.
Watson PG; Pattman RS
Int J STD AIDS; 1996 Jul; 7(4):296-7. PubMed ID: 8876365
[No Abstract] [Full Text] [Related]
33. [Sensitivity of Trichomonas to flagyl and its importance in the treatment of Trichomonas infection in women].
Starostina ZD
Vestn Dermatol Venerol; 1973 Oct; 47(10):84-5. PubMed ID: 4544528
[No Abstract] [Full Text] [Related]
34. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
[TBL] [Abstract][Full Text] [Related]
35. A study on the in vitro susceptibility of Trichomonas vaginalis to metronidazole.
Lin PR; Shaio MF
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Feb; 27(1):38-45. PubMed ID: 9747331
[TBL] [Abstract][Full Text] [Related]
36. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report.
Tayal S
Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518
[TBL] [Abstract][Full Text] [Related]
37. Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain.
Krajden S; Lossick JG; Wilk E; Yang J; Keystone JS; Elliott K
CMAJ; 1986 Jun; 134(12):1373-4. PubMed ID: 3486706
[No Abstract] [Full Text] [Related]
38. [A strain of Trichomonas vaginalis with reduced sensitivity for metronidazole].
Dijkmans BA; Polderman AM; Heintz AP; van Furth R
Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2193-5. PubMed ID: 6983659
[No Abstract] [Full Text] [Related]
39. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis.
Walker PP; Hall RE; Wilson JD
Int J STD AIDS; 1997 Jul; 8(7):473. PubMed ID: 9228600
[No Abstract] [Full Text] [Related]
40. Managing trichomonal vaginitis refractory to conventional treatment with metronidazole.
Ahmed-Jushuf IH; Murray AE; McKeown J
Genitourin Med; 1988 Feb; 64(1):25-9. PubMed ID: 3278971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
